5Satoh S,Hasegawa S,Ozaki N,et al.Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination[J].Gastric Cancer,2006,9(2):129-135.
6D'Ugo D,Persiani R,Rausei S,et al.Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer[J].Eur J Surg Oncol,2006,32(10):1105-1109.
9Ajani JA,Mansfield PF,Janjan N,et al.Multi-institutional trial of preoperateive chemoradiotherapy in patients with potentially re spectable gastric carcinoma[J].J Clin Oncol,2004,22(14):2774-2780.
10Ajani JA,Winter K,Okawara GS,et al.Phase Ⅱ trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904):quality of combined modality therapy and pathologic response[J].J Clin Oncol,2006,24(24):3953-3958.
8Satoh S,Hasegawa S,Ozaki N,et al.Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination[J].Gastric Cancer,2006,9(2):129-135.
9Mizoshita T,Kataoka H,Kubota E,et al.Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil[J].Int J Clin Oncol,2008,13(4):373-376.
10Kamei T, Kitayama J, Yamashita H, et al. Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer [J]. World J Surg, 2009 , 33(6):1240-1246.
